These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20133839)

  • 41. Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.
    Ziehm T; Brener O; van Groen T; Kadish I; Frenzel D; Tusche M; Kutzsche J; Reiß K; Gremer L; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2016 Aug; 7(8):1088-96. PubMed ID: 27240424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation.
    Jeong JS; Ansaloni A; Mezzenga R; Lashuel HA; Dietler G
    J Mol Biol; 2013 May; 425(10):1765-81. PubMed ID: 23415897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.
    Esler WP; Stimson ER; Jennings JM; Vinters HV; Ghilardi JR; Lee JP; Mantyh PW; Maggio JE
    Biochemistry; 2000 May; 39(21):6288-95. PubMed ID: 10828941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM.
    Zhang R; Hu X; Khant H; Ludtke SJ; Chiu W; Schmid MF; Frieden C; Lee JM
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4653-8. PubMed ID: 19264960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide.
    Ashur-Fabian O; Segal-Ruder Y; Skutelsky E; Brenneman DE; Steingart RA; Giladi E; Gozes I
    Peptides; 2003 Sep; 24(9):1413-23. PubMed ID: 14706557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?
    Klein WL; Krafft GA; Finch CE
    Trends Neurosci; 2001 Apr; 24(4):219-24. PubMed ID: 11250006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
    van Helmond Z; Miners JS; Kehoe PG; Love S
    Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.
    Liao MC; Van Nostrand WE
    Biochemistry; 2010 Feb; 49(6):1127-36. PubMed ID: 20050683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and Nanomechanical Characterization of the HIV Tat-Amyloid β Peptide Multifibrillar Structures.
    Feng Q; Hong Y; Pradeep Nidamanuri N; Yang C; Li Q; Dong M
    Chemistry; 2020 Aug; 26(43):9449-9453. PubMed ID: 32167218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of amyloid-β plaque formation by α-synuclein.
    Bachhuber T; Katzmarski N; McCarter JF; Loreth D; Tahirovic S; Kamp F; Abou-Ajram C; Nuscher B; Serrano-Pozo A; Müller A; Prinz M; Steiner H; Hyman BT; Haass C; Meyer-Luehmann M
    Nat Med; 2015 Jul; 21(7):802-7. PubMed ID: 26099047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular architecture of Aβ fibrils grown in cerebrospinal fluid solution and in a cell culture model of Aβ plaque formation.
    Garvey M; Baumann M; Wulff M; Kumar ST; Markx D; Morgado I; Knüpfer U; Horn U; Mawrin C; Fändrich M; Balbach J
    Amyloid; 2016 Jun; 23(2):76-85. PubMed ID: 26972581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-seeding effects of amyloid β-protein and α-synuclein.
    Ono K; Takahashi R; Ikeda T; Yamada M
    J Neurochem; 2012 Sep; 122(5):883-90. PubMed ID: 22734715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.